Bridging for Drug-Device and Biologic-Device Combination Products: Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 19, 2019
July 6, 2020
b906c8bd-9549-44b2-903e-95838dcc4ec3
Related Documents
Myelodysplastic Syndromes: Developing Drug and Biological Products for Treatment: Draft Guidance for Industry
Guidance DocumentJuly 2, 2025Office of the Commissioner
Graft-versus-Host Diseases: Developing Drugs, Biological Products, and Certain Devices for Prevention or Treatment
Guidance DocumentSeptember 28, 2023Office of the Commissioner
ICH Q12: Implementation Considerations for FDA-Regulated Products: Draft Guidance for Industry
Guidance DocumentMay 20, 2021Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox